GeneBioTech Co. ,Ltd (KOSDAQ: A086060)
Health Care · Biotechnology · KR
₩4,665.00
-0.74% today · +2.4% 1Y
GeneBioTech Co. ,Ltd (KOSDAQ: A086060) operates in the Biotechnology industry within the Health Care sector. The company is valued at $28.98M.
Over the last twelve months the share price has gained 2.4%, trading between 3.52K and 5.99K.
Tweenvest scores GeneBioTech Co. ,Ltd across four factors: quality 75/100, value 51/100, growth 39/100, dividend 19/100. Its strongest factor is quality.
A086060 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.98M
- Revenue (TTM)
- $58.76M
- P/E
- 11.20
- EPS
- 416.61
- Dividend yield
- 1.07%
- Beta (5Y)
- 0.26
- 52-week high
- ₩5,990.00
- 52-week low
- ₩3,525.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.61M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.00 | +0.08% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.45 | +0.05% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.74 | -0.02% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €909.60 | +3.46% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $157.49 | -0.84% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.